Roche and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added three additional Research Use Only (RUO) test kits for...
Researchers at the Nagourney Cancer Institute and Metabolomycs, Inc. announced in issue of PLOS ONE-a study that showed that COVID-19 related illness severity and...
The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz)
Also...
Individuals infected by COVID-19 are experiencing brain fog as a lasting symptom, more than six months past initial infection. While healthcare systems are currently...
